Back to People & Entities
Convergence/Calchan Pharmaceuticals
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
New Leaf Ventures III LP - PPM (Control 257 - Boris Nicolik).pdf
1 mentionHOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
Source: House Oversight Committee
Therapeutics (NLV-I, exited in sale to Astra Zeneca, 2.5x multiple plus milestones), Relypsa (NLV-I,_ private initially, now public on NASDAQ: RLYP), Convergence/Calchan Pharmaceuticals (NLV-IL, one start up that subsequently split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilyp
Sponsored
Connected Entities
No connected entities